Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach

HEK293T cells are extensively utilized for therapeutic protein production due to their human origin, which enables accurate post-translational modifications. This study aimed to enhance membrane protein production in HEK293T cells by knocking out the ATF4 gene using CRISPR-Cas9 technology. The ATF4...

Full description

Saved in:
Bibliographic Details
Main Authors: Byung-Jo Choi, Ba Reum Kim, Ho Joong Choi, Ok-Hee Kim, Say-June Kim
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-01-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/11519
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591171341254656
author Byung-Jo Choi
Ba Reum Kim
Ho Joong Choi
Ok-Hee Kim
Say-June Kim
author_facet Byung-Jo Choi
Ba Reum Kim
Ho Joong Choi
Ok-Hee Kim
Say-June Kim
author_sort Byung-Jo Choi
collection DOAJ
description HEK293T cells are extensively utilized for therapeutic protein production due to their human origin, which enables accurate post-translational modifications. This study aimed to enhance membrane protein production in HEK293T cells by knocking out the ATF4 gene using CRISPR-Cas9 technology. The ATF4 gene was edited by infecting HEK293T cells with a lentivirus carrying optimized single-guide RNA (ATF4-KO-3) and Cas9 genes. Comparative evaluations were conducted using all-in-one and two-vector systems. Genome sequencing and membrane protein productivity of ATF4-KO cells were compared to wild-type cells using next-generation sequencing (NGS) and a membrane protein isolation kit, respectively. Single-cell analysis confirmed gene editing patterns, with NGS verifying the intended deletions. Membrane protein production was also assessed indirectly via flow cytometry, analyzing cells expressing Membrane-GFP. Compared to wild-type cells, ATF4-KO cells exhibited a significant increase in membrane protein production, with a 52.2 ± 19.0% improvement. Gene editing efficiency was compared between the two delivery systems, with the two-vector system demonstrating higher efficiency based on T7E1 assays. Western blot analysis confirmed ATF4 suppression and increased expression of membrane proteins, including E-cadherin and CD63. Quantitative analysis via PAGE revealed a 77.2 ± 30.6% increase in purified membrane protein yields, consistent with the observed enhancements. Flow cytometry using Membrane-GFP further demonstrated a 22.9 ± 9.7% increase in productivity. In summary, ATF4 knockout significantly enhances membrane protein production in HEK293T cells, offering potential improvements in biopharmaceutical manufacturing by enabling more efficient protein synthesis.
format Article
id doaj-art-77f429b36aee4d10a521111a6ddf3628
institution Kabale University
issn 2831-0896
2831-090X
language English
publishDate 2025-01-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj-art-77f429b36aee4d10a521111a6ddf36282025-01-22T16:40:58ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2025-01-0110.17305/bb.2024.11519Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approachByung-Jo Choi0Ba Reum Kim1Ho Joong Choi2Ok-Hee Kim3Say-June Kim4Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Central Laboratory of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaTranslational Research Team, Surginex Co., Republic of KoreaDepartment of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaCatholic Central Laboratory of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Translational Research Team, Surginex Co., Republic of KoreaCatholic Central Laboratory of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Translational Research Team, Surginex Co., Republic of Korea; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea HEK293T cells are extensively utilized for therapeutic protein production due to their human origin, which enables accurate post-translational modifications. This study aimed to enhance membrane protein production in HEK293T cells by knocking out the ATF4 gene using CRISPR-Cas9 technology. The ATF4 gene was edited by infecting HEK293T cells with a lentivirus carrying optimized single-guide RNA (ATF4-KO-3) and Cas9 genes. Comparative evaluations were conducted using all-in-one and two-vector systems. Genome sequencing and membrane protein productivity of ATF4-KO cells were compared to wild-type cells using next-generation sequencing (NGS) and a membrane protein isolation kit, respectively. Single-cell analysis confirmed gene editing patterns, with NGS verifying the intended deletions. Membrane protein production was also assessed indirectly via flow cytometry, analyzing cells expressing Membrane-GFP. Compared to wild-type cells, ATF4-KO cells exhibited a significant increase in membrane protein production, with a 52.2 ± 19.0% improvement. Gene editing efficiency was compared between the two delivery systems, with the two-vector system demonstrating higher efficiency based on T7E1 assays. Western blot analysis confirmed ATF4 suppression and increased expression of membrane proteins, including E-cadherin and CD63. Quantitative analysis via PAGE revealed a 77.2 ± 30.6% increase in purified membrane protein yields, consistent with the observed enhancements. Flow cytometry using Membrane-GFP further demonstrated a 22.9 ± 9.7% increase in productivity. In summary, ATF4 knockout significantly enhances membrane protein production in HEK293T cells, offering potential improvements in biopharmaceutical manufacturing by enabling more efficient protein synthesis. https://www.bjbms.org/ojs/index.php/bjbms/article/view/11519CRISPR-Cas9gene editingHEK293T cellsATF4 knockoutmembrane protein production
spellingShingle Byung-Jo Choi
Ba Reum Kim
Ho Joong Choi
Ok-Hee Kim
Say-June Kim
Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
Biomolecules & Biomedicine
CRISPR-Cas9
gene editing
HEK293T cells
ATF4 knockout
membrane protein production
title Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
title_full Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
title_fullStr Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
title_full_unstemmed Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
title_short Enhanced membrane protein production in HEK293T cells via ATF4 gene knockout: A CRISPR-Cas9 mediated approach
title_sort enhanced membrane protein production in hek293t cells via atf4 gene knockout a crispr cas9 mediated approach
topic CRISPR-Cas9
gene editing
HEK293T cells
ATF4 knockout
membrane protein production
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/11519
work_keys_str_mv AT byungjochoi enhancedmembraneproteinproductioninhek293tcellsviaatf4geneknockoutacrisprcas9mediatedapproach
AT bareumkim enhancedmembraneproteinproductioninhek293tcellsviaatf4geneknockoutacrisprcas9mediatedapproach
AT hojoongchoi enhancedmembraneproteinproductioninhek293tcellsviaatf4geneknockoutacrisprcas9mediatedapproach
AT okheekim enhancedmembraneproteinproductioninhek293tcellsviaatf4geneknockoutacrisprcas9mediatedapproach
AT sayjunekim enhancedmembraneproteinproductioninhek293tcellsviaatf4geneknockoutacrisprcas9mediatedapproach